Latest News & Updates
Exclusive Offer for In-House Counsel
A select number of complimentary passes are available for qualified In-House Counsel for a limited time. Apply now to join the event at no cost.
Learn MoreView the Full Agenda
Explore in-depth sessions on policies, IP battles, and commercialization strategies shaping the future of advanced therapeutics. The complete agenda is now available—see what’s in store for this year’s event.
View AgendaUniting Innovation, Law, and Strategy in RNA, Cell and Gene Therapy, and Regenerative Medicines
ACI’s Forum on Advanced Therapeutics returns with a renewed focus on the dynamic forces shaping the future of RNA, cell and gene therapies, and regenerative medicine. Designed for professionals across legal, regulatory, scientific, and business functions, the event dives into the evolving landscape of policy, IP, funding, innovation, and commercialization.
Join us in Boston on March 25–26 to learn how your companies and clients can drive forward the most groundbreaking developments in advanced therapeutics, marrying scientific discovery with strategic business and legal acumen for global impact.
From AI in drug discovery to navigating market access and compliance, this forum offers practical insights and connections that help bring next-generation treatments to life.
Attend to engage with leading industry thought leaders and legal pioneers who will illuminate the path from groundbreaking research to global market success. Join the community driving meaningful advancement in advanced therapeutics.
Conference Co-Chairs
Rupa Cornell
VP, Legal Commercialization and Head of Compliance
Astria Therapeutics
Julie Tierney
Principal
Leavitt Partners
Former Deputy Director, U.S. Food and Drug Administration, Center for Biologics Evaluation & Research (CBER)
Jackie Wright Bonilla
Director
Sterne, Kessler, Goldstein & Fox
Former Deputy Chief Patent Judge, U.S. Patent and Trademark Office (USPTO)
Tamara Joseph
Chief Legal Officer
AIRNA Corporation
FDA Keynote
Amy Comstock Rick
Director, Rare Disease Innovation Hub
U.S. Food and Drug Administration
Advisory Board
Created as part of ACI’s commitment to delivering forward-thinking content, the Advisory Board for the Forum on Advanced Therapeutics provides insight into the legal, regulatory, and commercial forces shaping RNA, cell and gene therapies, and regenerative medicine.
In-House Insights From
- Astria Therapeutics
- Biogen
- Institute for Gene Therapies
- Intellia Therapeutics
- Lexeo Therapeutics
- Novartis
- Orchard Therapeutics
- Ring Therapeutics
- Takeda
Sponsors & Partners
Supporting Sponsor
Associate Sponsors
Media Partners
Sponsor Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Aaron Goldstein
Senior Business Development Manager
Email: [email protected]
